by Desiree Cobb-Olori | Mar 27, 2025
Daniel Havas, Kristina Locker-Kovacovicova, Smriti Mongia Objective: Histological detection of amyloids in human and mouse brain tissue is complex. Fibril structures and aggregation lead to a reduction of relevant epitopes for primary antibody detection and some...
by Desiree Cobb-Olori | Mar 27, 2025
Johana Bastidas1, Megan R. Detloff2, Linda Jones3, Marco Baptista3, Karim Fouad4, Wolfram Tetzlaff5, Taleen Hanania1. 1 Psychogenics, Paramus, New Jersey, US.2 Department of Neurobiology & Anatomy, Marion Murray Spinal Cord Research Center, Drexel University...
by Josh Troop | Nov 19, 2024
PsychoGenics, in collaboration with the Christopher Reeve Foundation, has validated the first standardized thoracic (T8) contusion model for spinal cord injury (SCI) research. This groundbreaking model is reshaping how SCI therapeutics are tested, making the discovery...
by Kelly Morris | Oct 15, 2024
Elizabeth A. Dugan2 , David Budac2, Briana Stanfield2, Mark Urban2, Vicki E. Brings1, Sarah A. Woller1, Smriti Iyengar1, Taleen Hanania2, Mark A. Varney21Division of Translational Research, National Institutes of Neurological Disorders and Stroke, National Institutes...
by Kelly Morris | Oct 15, 2024
Herman B. Fernandes, Jose Beltran, Mei Kwan, John Shea, Daniel Havas, Afshin Ghavami, Taleen Hanania Amyotrophic lateral sclerosis (ALS) is a neurodegenerative motor neuron disease characterized by specific cell death of the upper and/or lower motor neurons. The...
